Samira Sakhia

Samira Sakhia has a diverse and extensive work experience. Samira is currently the President and Chief Executive Officer at Knight Therapeutics Inc., a position they have held since September 2021. Prior to this role, they served as the President and Chief Operating Officer at the same company from June 2020 to September 2021. From August 2016 to June 2020, they were the President of Knight Therapeutics Inc.

In addition to their current position, Samira Sakhia holds various leadership roles in other organizations. Samira is a Director at Dollarama L.P. since June 2021. Samira also served as a Board Member at Profound Medical Inc. from March 2017 to June 2019, and as a Member of the Board of Directors at Crescita Therapeutics Inc. from October 2016 to May 2019. Furthermore, they were a Board Member at Antibe Therapeutics Inc. from May 2014 to March 2018, and a Member of the Board of Directors at Nuvo Pharmaceuticals Inc. from November 2015 to June 2017.

Prior to their roles in the pharmaceutical industry, Samira Sakhia held significant positions in other companies. From July 2001 to May 2015, they were the Chief Financial Officer at Paladin Labs Inc. Before that, they worked at Discreet Logic, where they served as the European Financial Manager from April 1997 to June 1999, and as the Financial Reporting Manager from April 1995 to April 1997. Samira began their career as a Senior Auditor at Arthur Andersen & Co. in August 1991, and later became a Staff Auditor from January 1991 to August 1993.

Overall, Samira Sakhia has demonstrated a strong track record of leadership and expertise in various industries, particularly in the pharmaceutical sector.

Samira Sakhia obtained a B.Comm degree in Accounting and Finance from McGill University in 1999-2000. Samira also completed an MBA during the same period.